US Stock MarketDetailed Quotes

MBX Biosciences (MBX)

Watchlist
  • 31.000
  • -1.860-5.66%
Close Apr 10 16:00 ET
  • 31.000
  • 0.0000.00%
Post 20:01 ET
1.47BMarket Cap-13.03P/E (TTM)

MBX Biosciences (MBX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-46.21%-79.95M
-14.12%-18.3M
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
-13.27M
-10.71M
Net income from continuing operations
-40.45%-86.97M
-41.55%-22.06M
-19.16%-21.62M
-22.41%-19.41M
-93.56%-23.88M
-90.16%-61.92M
-76.25%-15.59M
-78.51%-18.14M
---15.86M
---12.34M
Depreciation and amortization
1.64%248K
3.45%60K
-33.33%50K
-3.17%61K
60.42%77K
55.41%244K
41.46%58K
87.50%75K
--63K
--48K
Other non cash items
25.47%133K
18.52%32K
18.52%32K
48.15%40K
16.00%29K
11.58%106K
8.00%27K
12.50%27K
--27K
--25K
Change In working capital
-65.74%1.58M
350.08%1.57M
-154.53%-1.51M
-54.53%918K
38.25%600K
725.44%4.6M
78.05%-627K
54.63%2.77M
--2.02M
--434K
-Change in prepaid assets
-14.86%-2.7M
-94.85%-2.01M
-171.53%-1.55M
31.35%-795K
303.92%1.65M
-124.26%-2.35M
22.16%-1.03M
-562.60%-569K
---1.16M
--408K
-Change in payables and accrued expense
-38.86%4.34M
712.67%3.59M
-100.12%-4K
-45.32%1.76M
-1,696.83%-1.01M
1,453.17%7.1M
129.64%442K
98.24%3.38M
--3.22M
--63K
-Change in other current assets
---493K
--8K
--65K
----
----
--0
--0
--0
----
----
-Change in other current liabilities
377.78%425K
32.50%-27K
28.95%-27K
1,471.05%521K
-13.51%-42K
-11.68%-153K
-14.29%-40K
-8.57%-38K
---38K
---37K
Cash from discontinued investing activities
Operating cash flow
-46.21%-79.95M
-14.12%-18.3M
-46.86%-21.54M
-31.38%-17.43M
-111.75%-22.68M
-71.00%-54.68M
-43.88%-16.04M
-89.80%-14.66M
---13.27M
---10.71M
Investing cash flow
Cash flow from continuing investing activities
47.88%-83.71M
-93.00%-129.97M
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
-7.89M
15.43M
Net PPE purchase and sale
-120.71%-1.93M
-761.96%-793K
-600.00%-399K
-56.42%-707K
89.01%-30K
-577.52%-874K
-67.27%-92K
-159.09%-57K
---452K
---273K
Net investment purchase and sale
48.80%-81.78M
-92.08%-129.18M
117.33%17.46M
458.83%26.69M
-79.26%3.26M
-418.61%-159.72M
-132.71%-67.25M
-442.06%-100.73M
---7.44M
--15.7M
Cash from discontinued investing activities
Investing cash flow
47.88%-83.71M
-93.00%-129.97M
116.92%17.06M
429.31%25.99M
-79.09%3.23M
-419.27%-160.6M
-132.59%-67.35M
-441.73%-100.79M
---7.89M
--15.43M
Financing cash flow
Cash flow from continuing financing activities
-19.01%189.59M
431.82%438K
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
-1.76M
183K
Net common stock issuance
7.68%187.95M
--0
----
----
----
--174.54M
--0
----
----
----
Net preferred stock issuance
--0
--0
----
----
----
-7.31%63.5M
--0
----
----
----
Proceeds from stock option exercised by employees
499.26%2.42M
389.74%955K
519.35%130K
2,552.00%1.33M
-97.88%4K
-45.47%403K
926.32%195K
-282.35%-31K
--50K
--189K
Net other financing activities
82.24%-771K
-58.10%-517K
----
----
----
-14,370.00%-4.34M
---327K
---2.2M
---1.81M
---6K
Cash from discontinued financing activities
Financing cash flow
-19.01%189.59M
431.82%438K
-20.35%187.82M
175.30%1.33M
-97.81%4K
238.21%234.1M
-794.74%-132K
244.27%235.81M
---1.76M
--183K
Net cash flow
Beginning cash position
61.68%49.35M
67.93%223.13M
218.17%39.78M
-15.59%29.9M
61.68%49.35M
26.08%30.52M
88.18%132.87M
-56.04%12.5M
--35.43M
--30.52M
Current changes in cash
37.76%25.94M
-77.02%-147.84M
52.33%183.34M
143.09%9.88M
-496.74%-19.45M
198.24%18.83M
-108.36%-83.51M
185.45%120.36M
---22.92M
--4.9M
End cash Position
52.56%75.29M
52.56%75.29M
67.93%223.13M
218.17%39.78M
-15.59%29.9M
61.68%49.35M
61.68%49.35M
88.18%132.87M
--12.5M
--35.43M
Free cash flow
-47.38%-81.88M
-18.38%-19.09M
-49.00%-21.94M
-32.20%-18.14M
-106.76%-22.71M
-73.03%-55.56M
-44.00%-16.13M
-90.00%-14.72M
---13.72M
---10.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -46.21%-79.95M-14.12%-18.3M-46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M-13.27M-10.71M
Net income from continuing operations -40.45%-86.97M-41.55%-22.06M-19.16%-21.62M-22.41%-19.41M-93.56%-23.88M-90.16%-61.92M-76.25%-15.59M-78.51%-18.14M---15.86M---12.34M
Depreciation and amortization 1.64%248K3.45%60K-33.33%50K-3.17%61K60.42%77K55.41%244K41.46%58K87.50%75K--63K--48K
Other non cash items 25.47%133K18.52%32K18.52%32K48.15%40K16.00%29K11.58%106K8.00%27K12.50%27K--27K--25K
Change In working capital -65.74%1.58M350.08%1.57M-154.53%-1.51M-54.53%918K38.25%600K725.44%4.6M78.05%-627K54.63%2.77M--2.02M--434K
-Change in prepaid assets -14.86%-2.7M-94.85%-2.01M-171.53%-1.55M31.35%-795K303.92%1.65M-124.26%-2.35M22.16%-1.03M-562.60%-569K---1.16M--408K
-Change in payables and accrued expense -38.86%4.34M712.67%3.59M-100.12%-4K-45.32%1.76M-1,696.83%-1.01M1,453.17%7.1M129.64%442K98.24%3.38M--3.22M--63K
-Change in other current assets ---493K--8K--65K----------0--0--0--------
-Change in other current liabilities 377.78%425K32.50%-27K28.95%-27K1,471.05%521K-13.51%-42K-11.68%-153K-14.29%-40K-8.57%-38K---38K---37K
Cash from discontinued investing activities
Operating cash flow -46.21%-79.95M-14.12%-18.3M-46.86%-21.54M-31.38%-17.43M-111.75%-22.68M-71.00%-54.68M-43.88%-16.04M-89.80%-14.66M---13.27M---10.71M
Investing cash flow
Cash flow from continuing investing activities 47.88%-83.71M-93.00%-129.97M116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M-7.89M15.43M
Net PPE purchase and sale -120.71%-1.93M-761.96%-793K-600.00%-399K-56.42%-707K89.01%-30K-577.52%-874K-67.27%-92K-159.09%-57K---452K---273K
Net investment purchase and sale 48.80%-81.78M-92.08%-129.18M117.33%17.46M458.83%26.69M-79.26%3.26M-418.61%-159.72M-132.71%-67.25M-442.06%-100.73M---7.44M--15.7M
Cash from discontinued investing activities
Investing cash flow 47.88%-83.71M-93.00%-129.97M116.92%17.06M429.31%25.99M-79.09%3.23M-419.27%-160.6M-132.59%-67.35M-441.73%-100.79M---7.89M--15.43M
Financing cash flow
Cash flow from continuing financing activities -19.01%189.59M431.82%438K-20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M-1.76M183K
Net common stock issuance 7.68%187.95M--0--------------174.54M--0------------
Net preferred stock issuance --0--0-------------7.31%63.5M--0------------
Proceeds from stock option exercised by employees 499.26%2.42M389.74%955K519.35%130K2,552.00%1.33M-97.88%4K-45.47%403K926.32%195K-282.35%-31K--50K--189K
Net other financing activities 82.24%-771K-58.10%-517K-------------14,370.00%-4.34M---327K---2.2M---1.81M---6K
Cash from discontinued financing activities
Financing cash flow -19.01%189.59M431.82%438K-20.35%187.82M175.30%1.33M-97.81%4K238.21%234.1M-794.74%-132K244.27%235.81M---1.76M--183K
Net cash flow
Beginning cash position 61.68%49.35M67.93%223.13M218.17%39.78M-15.59%29.9M61.68%49.35M26.08%30.52M88.18%132.87M-56.04%12.5M--35.43M--30.52M
Current changes in cash 37.76%25.94M-77.02%-147.84M52.33%183.34M143.09%9.88M-496.74%-19.45M198.24%18.83M-108.36%-83.51M185.45%120.36M---22.92M--4.9M
End cash Position 52.56%75.29M52.56%75.29M67.93%223.13M218.17%39.78M-15.59%29.9M61.68%49.35M61.68%49.35M88.18%132.87M--12.5M--35.43M
Free cash flow -47.38%-81.88M-18.38%-19.09M-49.00%-21.94M-32.20%-18.14M-106.76%-22.71M-73.03%-55.56M-44.00%-16.13M-90.00%-14.72M---13.72M---10.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More